Cholinesterase inhibitor donepezil dilates cerebral parenchymal arterioles via the activation of neuronal nitric oxide synthase

Anesthesiology

Volumn 109, Issue 1, 2008, Pages 124-129

  Kinoshita, Hiroyuki ^b   Nakahata, Katsutoshi ^a   Hama Tomioka, Keiko ^a   Ishida, Yuko ^a   Matsuda, Naoyuki ^c   Hatakeyama, Noboru ^d   Haba, Masanori ^a   Kondo, Toshikazu ^b   Hatano, Yoshio ^a  

^a Department of Anesthesiology ^*

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; DONEPEZIL; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN F2 ALPHA; S METHYLTHIOCITRULLINE; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

ANIMAL TISSUE; ARTERIOLE; ARTERY WALL; ARTICLE; BRAIN BLOOD VESSEL; BRAIN SLICE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION; WISTAR RAT; ANIMAL; BRAIN; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; ARTERIOLES; BRAIN; CHOLINESTERASE INHIBITORS; ENZYME ACTIVATION; INDANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE I; PIPERIDINES; RATS; RATS, WISTAR; VASODILATION;

EID: 48949118959     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31817c0316     Document Type: Article

References (33)

1. Sugimoto H, Ogura H, Arai Y, Imura Y, Yamanishi Y: Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn J Pharmacol 2002; 89:7-20
2. Bartus RT, Dean RL3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;30: 408-14
3. Perry EK: The cholinergic hypothesis - ten years on. Br Med Bull 1986; 42:63-9
4. Benagiano V, Virgintino D, Rizzi A, Errede M, Bertossi V, Troccoli L, Roncali L, Ambrosi G: Cholinergic nerve fibres associated with the microvessels of the human cerebral cortex: a study based on monoclonal immunocytochemistry for choline acetyltransferase. EurJ Histochem 2000; 44:165-9
5. Saito A, Wu JY, Lee TJ: Evidence for the presence of cholinergic nerves in cerebral arteries: An immunohistochemical demonstration of choline acetyltransferase. J Cereb Blood Flow Metab 1985; 5:327-34
6. Lacombe P, Sercombe R, Vaucher E, Seylaz J: Reduced cortical vasodilatory response to stimulation of the nucleus basalis of Meynert in the aged rat and evidence for a control of the cerebral circulation. Ann NY Acad Sci 1997; 826:410-5
7. Toda N, Ayajiki K, Okamura T: Inhibition of nitroxidergic nerve function by neurogenic acetylcholine in monkey cerebral arteries. J Physiol 1997; 498: 453-61
8. Nakahata K, Kinoshita H, Azma T, Matsuda N, Hama-Tomioka K, Haba M, Hatano Y: Propofol restores brain microvascular function impaired by high glucose via the decrease in oxidative stress. ANESTHESIOLOGY 2008; 108:269-75
9. Geaney DP, Soper N, Shepstone BJ, Cowen PJ: Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease. Lancet 1990; 335:1484-7
10. Eberling JL, Jagust WJ, Reed BR, Baker MG: Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 1992; 13:483-91
11. Tong XK, Hamel E: Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neuron in Alzheimer's disease. Neuroscience 1999; 92:163-75
12. Postiglione A, Lassen NA, Holman BL: Cerebral blood flow in patients with dementia of Alzheimer's type. Aging 1993; 5:19-26
13. Kasa P, Papp H, Kasa P Jr, Torok I: Donepezil dose-dependently inhibits acethylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain. Neuroscience 2000; 101:89-100
14. Winblad B, Kilander L, Eriksson S, Minthon L, Batsman S, Wetterholm AL, Jansson-Blixt C, Haglund A. Severe Alzheimer's Disease Study Group: Donepezil in patients with severe Alzheimer's disease: Double-blind, parallel-group, placebo-controlled study. Lancet 2006;367: 1057-65.
15. Nakano S, AsadaT, Matsuda H, Uno M, Takasaki M: Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med 2001; 42:1441-5
16. Hanyu H, Shimizu T, Tanaka Y, Takasaki M, Koizumi K, Abe K: Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2003; 15:177-82
17. Clayton BA, HayashidaK, Childers SR, Xiao R, Eisenach JC: Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism. ANESTHESIOLOGY 2007; 106:1019-25
18. Hayashida K, Parker R, Eisenach JC: Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil. ANESTHESIOLOGY 2007; 106:1213-9
19. + channels in parenchymal microvessels of the rat cerebral cortex. ANESTHESIOLOGY 2003; 99:1333-9
20. Peters A, Palay SL, Webster HF: Blood vessels, The Fine Structure of the Nervous System: Neurons and Their Supporting Cells, 3rd edition. Edited by Peters A, Palay SL, Webster HF. New York, Oxford University Press, 1991, pp 344-55
21. + channels in cerebral microvessels of hypertensive and normotensive rats. Anesth Analg 2006; 102:571-6
22. + channels in rat cerebral microvessels. Anesth Analg 2004; 99:904-9
23. Vaucher E, Linville D, Hamel E: Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex. Neuroscience 1997; 79:827-36
24. Hamel E: Cholinergic modulation of the cortical microvascular bed. Prog Brain Res 2004; 145:171-8
25. Perry EK, Tomlinson BE, Blessed G, Bergman K, Gibson PH, Perry RH: Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 1978; 25:1457-9
26. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delong MR: Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 1982; 215:1237-9
27. Yoshida T, Ha-Kawa S, Yoshimura M, Nobuhara K, Kinoshita T, Sawada S: Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease. Ann Nucl Med 2007; 21:257-65
28. Shimizu S, Hanyu H, IwamotoT, Koizumi K, Abe K: SPECT follow-up study of cerebral blood flow changes during donepezil therapy in patients with Alzheimer's disease. J Neuroimaging 2006; 16:16-23
29. Kinoshita H, Katusic ZS: Nitric oxide and effects of cationic polypeptides in canine cerebral arteries. J Cereb Blood Flow Metab 1997; 17:470-80
30. Zanzinger J, Czachurski J, Seller H: Neuronal nitric oxide reduces sympathetic excitability by modulation of central glutamate effects in pigs. Circ Res 1997; 80:565-71
31. Hamel E: Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 2006; 100:1059-64
32. Rogers SL, Doody RS, Mohs RC, Friedhoff LT: Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med 1998; 158:1021-31
33. Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A: Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J Pharmacol Exp Ther 2003; 306:772-7